CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies

Journal of Affective Disorders

Volumn 150, Issue 3, 2013, Pages 736-744

  Valkanova, Vyara ^a   Ebmeier, Klaus P ^a   Allan, Charlotte L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CRP; Depressive; IL 6; Inflammation; Longitudinal; Meta analysis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE MARKER; EFFECT SIZE; GENETIC HETEROGENEITY; HUMAN; LONGITUDINAL STUDY; META ANALYSIS; NERVE CELL PLASTICITY; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; SYSTEMATIC REVIEW;

CRP; DEPRESSIVE; IL-6; INFLAMMATION; LONGITUDINAL; META-ANALYSIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTERLEUKIN-6; MALE;

EID: 84888317074     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.06.004     Document Type: Review

References (58)

1. Alexopoulos, G.S., Morimoto, S.S., 2011 Nov. The inflammation hypothesis in geriatric depression. International Journal of Geriatric Psychiatry, http://dx. doi.org/10.1002/gps.2672, in press.
2. Apostolakis, S., Vogiatzi, K., Krambovitis, E., Spandidos, D.A., 2008. IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications. Cardiovascular and Hematological Agents in Medicinal Chemistry 6, 150-158.
3. Bonaccorso, S., Marino, V., Biondi, M., Grimaldi, F., Ippoliti, F., Maes, M., 2002. Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. Journal of Affective Disorders 72, 237-241.
4. Capuron, L., Gumnick, J.F., Musselman, D.L., Lawson, D.H., Reemsnyder, A., Nemeroff, C.B., Miller, A.H., 2002. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26, 643-652.
5. Capuron, L., Miller, A.H., 2011. Immune system to brain signaling: neuropsycho-pharmacological implications. Pharmacology and Therapeutics 130, 226-238.
6. Capuron, L., Pagnoni, G., Demetrashvili, M., Woolwine, B.J., Nemeroff, C.B., Berns, G. S., Miller, A.H., 2005. Anterior cingulate activation and error processing during interferon-alpha treatment. Biological Psychiatry 58, 190-196.
7. Copeland, W.E., Shanahan, L., Worthman, C., Angold, A., Costello, E.J., 2012. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biological Psychiatry 71, 15-21.
8. Danese, A., Moffitt, T.E., Pariante, C.M., Ambler, A., Poulton, R., Caspi, A., 2008. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Archives of General Psychiatry 65, 409-116.
9. Dantzer, R., 2004. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. European Journal of Pharmacology 500, 399-411.
10. Dantzer, R., Kelley, K.W., 2007. Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity 21, 153-160.
11. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9, 46-56.
12. Deverts, D.J., Cohen, S., DiLillo, V.G., Lewis, C.E., Kiefe, C., Whooley, M., Matthews, K. A., 2010. Depressive symptoms, race, and circulating C-reactive protein: the coronary artery risk development in young adults (CARDIA) study. Psychosomatic Medicine 72, 734-741.
13. Dilger, R.N., Johnson, R.W., 2008. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. Journal of Leukocyte Biology 84, 932-939.
14. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67, 446-457.
15. Drevets, W.C., Savitz, J., Trimble, M., 2008. The subgenual anterior cingulate cortex in mood disorders. CNS Spectrums 13, 663-681. Englewood, N.J., 2006. Comprehensive Meta-Analysis 2.2.048. Biostat.: USA.
16. Gimeno, D., Kivimaki, M., Brunner, E.J., Elovainio, M., De Vogli, R., Steptoe, A., Kumari, M., Lowe, G.D., Rumley, A., Marmot, M.G., Ferrie, J.E., 2009. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychological Medicine 39, 413-423.
17. Glaser, R., Robles, T.F., Sheridan, J., Malarkey, W.B., Kiecolt-Glaser, J.K., 2003. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Archives of General Psychiatry 60, 1009-1014.
18. Hamer, M., Molloy, G.J., de Oliveira, C., Demakakos, P., 2009. Persistent depressive symptomatology and inflammation: to what extent do health behaviours and weight control mediate this relationship? Brain, Behavior, and Immunity 23, 413-418.
19. Hannestad, J., DellaGioia, N., Bloch, M., 2011. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36, 2452-2459.
20. Harrison, N.A., Brydon, L., Walker, C., Gray, M.A., Steptoe, A., Critchley, H.D., 2009. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biological Psychiatry 66, 407-114.
21. Howren, M.B., Lamkin, D.M., Suls, J., 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71, 171-186.
22. Khairova, R.A., Machado-Vieira, R., Du, J., Manji, H.K., 2009. A potential role for proinflammatory cytokines in regulating synaptic plasticity in major depressive disorder. International Journal of Neuropsychopharmacology 12, 561-578.
23. Kiecolt-Glaser, J.K., Preacher, K.J., MacCallum, R.C., Atkinson, C., Malarkey, W.B., Glaser, R., 2003. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the National Academy of Sciences USA 100, 9090-9095.
24. Kivimäki, M., Shipley, M.J., Batty, G.D., Hamer, M., Akbaraly, T.N., Kumari, M., Jokela, M., Virtanen, M., Lowe, G.D., Ebmeier, K.P., Brunner, E.J., Singh-Manoux, A., 2013Apr 9. Long-term inflammation increases risk of common mental disorder: a cohort study. Molecular Psychiatry, http://dx.doi.org/10.1038/mp.2013.35, in press.
25. Krabbe, K.S., Pedersen, M., Bruunsgaard, H., 2004. Inflammatory mediators in the elderly. Experimental Gerontology 39, 687-699.
26. Krishnadas, R., Cavanagh, J., 2012. Depression: an inflammatory illness? Journal of Neurology, Neurosurgery and Psychiatry 83, 495-502.
27. Lanquillon, S., Krieg, J.C., Bening-Abu-Shach, U., Vedder, H., 2000. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22, 370-379.
28. Lautner, R., Mattsson, N., Scholl, M., Augutis, K., Blennow, K., Olsson, B., Zetterberg, H., 2011. Biomarkers for microglial activation in Alzheimer's disease. International Journal of Alzheimer's Disease 2011, 939426.
29. Liu, Y., Ho, R.C., Mak, A., 2012. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2 R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. Journal of Affective Disorders 139, 230-239.
30. Maes, M., 2011. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35, 664-675.
31. Maes, M., Bosmans, E., Suy, E., Vandervorst, C., De Jonckheere, C., Raus, J., 1990. Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 24, 115-120.
32. Maes, M., Bosmans, E., Suy, E., Vandervorst, C., DeJonckheere, C., Raus, J., 1991. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatrica Scandinavica 84, 379-386.
33. Maes, M., Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Egyed, B., Dantzer, R., Neveu, P.J., 2001. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacol-ogy 24, 130-140.
34. Maes, M., Galecki, P., Chang, Y.S., Berk, M., 2011a. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35, 676-692.
35. Maes, M., Kubera, M., Obuchowiczwa, E., Goehler, L., Brzeszcz, J., 2011b. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuroendocrinology Letters 32, 7-24.
36. Maes, M., Leonard, B.E., Myint, A.M., Kubera, M., Verkerk, R., 2011c. The new '5-HT hypothesis of depression: cell-mediated immune activation induces indolea-mine 2, 3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35, 702-721.
37. Maes, M., Scharpe, S., Meltzer, H.Y., Bosmans, E., Suy, E., Calabrese, J., Cosyns, P., 1993. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Research 49, 11-27.
38. Maes, M., Song, C., Lin, A., De Jongh, R., Van Gastel, A., Kenis, G., Bosmans, E., De Meester, I., Benoy, I., Neels, H., Demedts, P., Janca, A., Scharpe, S., Smith, R.S., 1998. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10, 313-318.
39. Matheny, M.E., Miller, R.R., Shardell, M.D., Hawkes, W.G., Lenze, E.J., Magaziner, J., Orwig, D.L., 2011. Inflammatory cytokine levels and depressive symptoms in older women in the year after hip fracture: findings from the Baltimore hip studies. Journal of the American Geriatrics Society 59, 2249-2255.
40. Matthews, K.A., Schott, L.L., Bromberger, J.T., Cyranowski, J.M., Everson-Rose, S.A., Sowers, M., 2010. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women? Brain, Behavior, and Immunity 24, 96-101.
41. McNally, L., Bhagwagar, Z., Hannestad, J., 2008. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectrums 13, 501-510.
42. Milaneschi, Y., Corsi, A.M., Penninx, B.W., Bandinelli, S., Guralnik, J.M., Ferrucci, L., 2009. Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study. Biological Psychiatry 65, 973-978.
43. Moylan, S., Maes, M., Wray, N.R., Berk, M., 2013. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Molecular Psychiatry 18, 595-606.
44. Pasco, J.A., Nicholson, G.C., Williams, L.J., Jacka, F.N., Henry, M.J., Kotowicz, M.A., Schneider, H.G., Leonard, B.E., Berk, M., 2010. Association of high-sensitivity C-reactive protein with de novo major depression. British Journal of Psychiatry 197, 372-377.
45. Pascoe, M.C., Crewther, S.G., Carey, L.M., Crewther, D.P., 2011. Inflammation and depression: why poststroke depression may be the norm and not the exception. International Journal of Stroke 6, 128-135.
46. Raison, C.L., Miller, A.H., 2011. Is depression an inflammatory disorder? Current Psychiatry Reports 13, 467-475.
47. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., Haroon, E., Miller, A.H., 2012. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. Archives of General Psychiatry, 1-11.
48. Riemer, S., Maes, M., Christophe, A., Rief, W., 2010. Lowered omega-3 PUFAs are related to major depression, but not to somatization syndrome. Journal of Affective Disorders 123, 173-180.
49. Sluzewska, A., Nowakowska, E., Gryska, K., Mackiewicz, A., 1994. Haptoglobin levels in a chronic mild stress model of depression in rats before and after treatment. European Neuropsychopharmacology 4, 302.
50. Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M., Wiktorowicz, K., 1996. Indicators of immune activation in major depression. Psychiatry Research 64, 161-167.
51. Sparkman, N.L., Johnson, R.W., 2008. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 15, 323-330.
52. Steptoe, A., Hamer, M., Chida, Y., 2007. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain, Behavior, and Immunity 21, 901-912.
53. Stewart, J.C., Rand, K.L., Muldoon, M.F., Kamarck, T.W., 2009. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain, Behavior, and Immunity 23, 936-944.
54. Thomas, A.J., Davis, S., Morris, C., Jackson, E., Harrison, R., O'Brien, J.T., 2005. Increase in interleukin-1beta in late-life depression. American Journal of Psychiatry 162, 175-177.
55. van den Biggelaar, A.H., Gussekloo, J., de Craen, A.J., Frolich, M., Stek, M.L., van der Mast, R.C., Westendorp, R.G., 2007. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Experimental Gerontology 42, 693-701.
56. von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gotzsche, P.C., Vandenbroucke, J.P., 2007. The strengthening the reporting ofobservational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370, 1453-1457.
57. Von Kanel, R., Bellingrath, S., Kudielka, B.M., 2009. Association between longitudinal changes in depressive symptoms and plasma fibrinogen levels in school teachers. Psychophysiology 46, 473-480.
58. Yirmiya, R., 1997. Behavioral and psychological effects of immune activation: implications for 'depression due to a general medical condition'. Current Opinion in Psychiatry 10, 470-476.